The Ministry of Science and Technology as well as other governmental bodies in China are considering the implementation of a tax break or exemption for companies that invest in new drug development. Up to this time, China has not been a major... Read More
The Singaporean Ministry of Health (MOH) announced on August 20, 2002, that they are implementing new regulatory controls over Chinese proprietary medicines (CPMs). Due to the rise of recent health related problems as a result of CPM consumption, the Ministry is tightening... Read More
Slowing economies have not stopped Asian countries from moving ahead with medical device regulatory reforms. Asian consumers demand high-quality healthcare products, making it worthwhile for American manufactures to be active in the region. Procedures and practices vary according to country. This article... Read More
The China Compulsory Certification (CCC) mark has replaced the old China Commission for Conformity Certification of Electrical Equipment (CCEE) and China Commodity Inspection Bureau (CCIB) marks as of on May 1, 2002. The CCC will replace the previous certification systems as the... Read More
In recent years, the demand for natural products and supplements has skyrocketed worldwide, fuelled by increasing acceptance of traditional herbal medicines and popular consumer demand for alternative therapies. The Asian markets are a major part of this trend. With a strong history... Read More
With the world’s largest population and an immense pool of untreated patients, many who qualify for various clinical testing, China poses an attractive prospect for pharmaceutical companies. US drug manufacturers are realizing the untapped potential of testing in China. Most importantly, costs... Read More
Opportunities in China for medical device manufacturers have never been better. U.S. medical device exports to China are growing 12 percent annually. Sales to the Chinese mainland (excluding Hong Kong) reached US$275 million in 2001. U.S. exporters achieved an additional US$250 million... Read More
In line with its accession to the World Trade Organization (WTO), the Chinese government promulgated a new Drug Administrative Law effective December 2001. New clauses address drug quality control, labeling and advertising restrictions, and other issues related to safety and improving standards... Read More
China’s pharmaceutical market continues to grow by 10 to 15 percent per year. Many expect it to be the world’s largest pharmaceutical market by 2020, with sales topping US$60 billion by 2010. Imports from the U.S. accounted for 8.51% of the market... Read More
Recent estimates indicate that there are over 3,000 health food products sold on the market in China, including nutraceuticals, functional foods, and products based on Traditional Chinese Medicine (TCM). At least one source reports that total sales volume in China’s health food... Read More